Drug Recall

A class action in British Columbia Supreme Court claims Teva Canada, Sandoz Canada, et al. failed to warn patients prescribed Valsartan (hydrochlorothiazide) for hypertension that the drug was recalled as possibly carcinogenic, possibly because of contamination by its Chinese supplier.

VANCOUVER, B.C. — A class action in British Columbia Supreme Court claims Teva Canada, Sandoz Canada, et al. failed to warn patients prescribed Valsartan (hydrochlorothiazide) for hypertension that the drug was recalled as possibly carcinogenic, possibly because of contamination by its Chinese supplier.

Categories / Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Drug Recall

Subscribe to Closing Arguments

Additional Reads